Case-based approaches to T2DM and atrial fibrillation management

A leading expert discusses the role of a dipeptidyl peptidase-4 (DPP-4) inhibitor in managing an older patient with type 2 diabetes mellitus and chronic kidney disease, while an eminent specialist explores the efficacy of a direct oral anticoagulant and how a reversal agent can temporarily reverse its anticoagulation effect in a patient with atrial fibrillation.